These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 17214654)
1. Improving the selective neonatal BCG program. Wroe AL; McKeever C; Thackray S; Bhan A Public Health Nurs; 2007; 24(1):60-5. PubMed ID: 17214654 [TBL] [Abstract][Full Text] [Related]
2. Selective or universal neonatal BCG immunization: what policy for a district with a high incidence of tuberculosis? Pharoah PD; Watson JM; Sen S Public Health; 1996 May; 110(3):179-83. PubMed ID: 8668765 [TBL] [Abstract][Full Text] [Related]
3. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland. Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831 [TBL] [Abstract][Full Text] [Related]
4. Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis. Kelly P; McKeown D; Clancy L Eur Respir J; 1997 Mar; 10(3):619-23. PubMed ID: 9072995 [TBL] [Abstract][Full Text] [Related]
5. Delivering a selective neonatal BCG vaccination programme in a multi-ethnic community: an audit of the neonatal BCG immunisation programme in Birmingham and Solihull. Etuwewe O; Wood A; Lyon A Commun Dis Public Health; 2004 Sep; 7(3):172-6. PubMed ID: 15481207 [TBL] [Abstract][Full Text] [Related]
6. Audit of the implementation of selective neonatal BCG immunisation in south east London. Tseng E; Nesbitt A; O'Sullivan D Commun Dis Rep CDR Rev; 1997 Oct; 7(11):R165-8. PubMed ID: 9350094 [TBL] [Abstract][Full Text] [Related]
7. Implementing the new BCG vaccination guidelines--a maternity hospital-based clinic approach. Athavale D; McCullough S; Mactier H J Public Health (Oxf); 2006 Jun; 28(2):133-6. PubMed ID: 16549406 [TBL] [Abstract][Full Text] [Related]
10. Surgical complications of bacille Calmette-Guérin (BCG) infection in HIV-infected children: time for a change in policy. Karpelowsky JS; Alexander AG; Peek SD; Millar AJ; Rode H S Afr Med J; 2008 Oct; 98(10):801-4. PubMed ID: 19115758 [TBL] [Abstract][Full Text] [Related]
11. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines. Dierig A; Tebruegge M; Krivec U; Heininger U; Ritz N; Vaccine; 2015 Sep; 33(38):4994-9. PubMed ID: 26151543 [TBL] [Abstract][Full Text] [Related]
12. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial. Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384 [TBL] [Abstract][Full Text] [Related]
13. The success and failure of BCG - implications for a novel tuberculosis vaccine. Andersen P; Doherty TM Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514 [TBL] [Abstract][Full Text] [Related]
14. Vaccines for other neonatal infections: neonatal BCG vaccination against tuberculosis. Britton WJ Expert Rev Vaccines; 2004 Aug; 3(4):365-9. PubMed ID: 15270636 [TBL] [Abstract][Full Text] [Related]
15. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Menzies D Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826 [TBL] [Abstract][Full Text] [Related]
16. Relationship between NRAMP1 gene polymorphism and efficacy of BCG vaccine in a helminth-infected population. Badawy AA; Yahya RS; Awad SI; Al-Sawah GA; Kizilbash NA Genet Mol Res; 2013 Jan; 12(3):3048-56. PubMed ID: 23408448 [TBL] [Abstract][Full Text] [Related]
17. The effect of neonatal bacille Calmette-Guérin vaccination on purified protein derivative skin test results in Canadian aboriginal children. Reid JK; Ward H; Marciniuk D; Hudson S; Smith P; Hoeppner V Chest; 2007 Jun; 131(6):1806-10. PubMed ID: 17400666 [TBL] [Abstract][Full Text] [Related]
18. A new neonatal BCG vaccination pathway in England: a mixed methods evaluation of its implementation. Jones K; Chisnall G; Crocker-Buque T; Elliman D; Horwood J; Mounier-Jack S; Campbell CN; Saliba V; Chantler T BMC Public Health; 2024 Apr; 24(1):1175. PubMed ID: 38671383 [TBL] [Abstract][Full Text] [Related]
19. Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency. Sohail S; Afzal M; Anwar V; Shama Q J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S259-61. PubMed ID: 25518795 [TBL] [Abstract][Full Text] [Related]
20. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]